Novartis India Limited (NSE: NOVARTIND), ISIN INE234A01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NOVARTIND last traded at ₹1595.75 (+1.07%), with a 52-week range of ₹750.00 to ₹1777.50 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 70.68%, FIIs 0.19%, DIIs 0.64%, mutual funds 0.00%.
EquiSense Score (ECS): 48/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.